Evidence map›Paper›PMID 34743296›Full record

ArticleBrain imaging and behavior2022

Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer's disease.

Xiaoqi Wang, Min Wang, Xiaoni Wang, Feifan Zhou, Jiehui Jiang, Hesheng Liu, Ying Han

Abstract read
PubMed Publisher
In one paragraph

Article in Brain imaging and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Xiaoqi WangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Min WangKey Laboratory of Specialty Fiber Optics and Optical Access Networks, Joint International Research Laboratory of Specialty Fiber Optics and Advanced Communication, School of Information and Communication Engineering, Shanghai University, Shanghai, China.
Xiaoni WangDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Feifan ZhouSchool of Biomedical Engineering, Hainan University, Haikou, China.
Jiehui JiangKey Laboratory of Specialty Fiber Optics and Optical Access Networks, Joint International Research Laboratory of Specialty Fiber Optics and Advanced Communication, School of Information and Communication Engineering, Shanghai University, Shanghai, China. jiangjiehui@shu.edu.cn.
Hesheng LiuAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Ying HanDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. hanying@xwh.ccmu.edu.cn.ORCID http://orcid.org/0000-0003-0377-7424
Capital Medical University · CNShanghai University · CNHainan University · CNHarvard University · US

Funding

National Natural Science Foundation of China 61633018, 82020108013, 82001773
6 · The paper itself

Abstract

Subjective cognitive decline (SCD)-related worries are indicative of an increased risk for developing Alzheimer's disease (AD) dementia. However, the influence of SCD-related worries on the relationship between amyloid and gray matter (GM) atrophy remains unknown. A total of 93 SCD participants underwent

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsGray MatterHumansMagnetic Resonance ImagingPositron-Emission TomographyAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsAlzheimer’s diseaseAmyloidGray matterSubjective cognitive declineWorries

Identifiers

PMID34743296
OpenAlexW3211653617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.